Skip to content
Disclosery

NVP ASSOCIATES, LLC

Follow

13F filer, CIK 1545692, MENLO PARK, CA

NVP ASSOCIATES, LLC reported $184,154,231 across 7 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001415889-25-021886

Period
2025-06-30
Reported value
$184M
Holdings
7
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OMDAnew+2,531,000$46.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DAVEreduced-350,000-$93.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001415889-25-021886, largest first. % of portfolio is the value over $184,154,231, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DAVEDAVE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 582,675 shares; 2024Q4: 582,675 shares; 2025Q1: 582,675 shares; 2025Q2: 232,675 shares 232,675$62.5M33.91%-350,000Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,531,000 shares 2,531,000$46.3M25.15%newTimeline
TALKTALKSPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,702,972 shares; 2024Q4: 14,702,972 shares; 2025Q1: 9,802,972 shares; 2025Q2: 9,802,972 shares 9,802,972$27.3M14.8%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,136,335 shares; 2024Q4: 2,136,335 shares; 2025Q1: 2,136,335 shares; 2025Q2: 2,136,335 shares 2,136,335$24.4M13.24%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,838,482 shares; 2024Q4: 1,838,482 shares; 2025Q1: 1,838,482 shares; 2025Q2: 1,838,482 shares 1,838,482$17.8M9.67%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,943,522 shares; 2024Q4: 2,943,522 shares; 2025Q1: 3,225,097 shares; 2025Q2: 3,225,097 shares 3,225,097$3.71M2.01%0Timeline
OPENOPENDOOR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,189,562 shares; 2024Q4: 4,189,562 shares; 2025Q1: 4,189,562 shares; 2025Q2: 4,189,562 shares 4,189,562$2.23M1.21%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001415889-25-021886 base2025-08-14acceptance time not in the bulk data set